PARIS, July 18 (Reuters) - Publicis, the world’s third-biggest advertising group, cut its 2019 growth guidance on Thursday after reporting a weaker-than-expected performance in the second quarter as it
President Trump’s promise to lower prescription drugs prices has hit the buffers. His most-ambitious proposal, targeting rebates given to middlemen in the country’s highly complex medical system, has abandoned.
ZURICH (Reuters) - Switzerland has agreed to extradite a Chinese researcher to the United States where prosecutors have charged him with helping his scientist sister steal secrets allegedly worth $550
GlaxoSmithKline has unveiled promising results from a late-stage trial of an important oncology drug in the first sign that its new approach to research and development is starting to pay off. Zejula acquired
July 15 (Reuters) - GlaxoSmithKline said on Monday a late-stage study testing Zejula as a maintenance therapy in patients with first-line ovarian cancer showed positive headline results. GSK agreed to
The widow of a Reed Smith partner who killed himself while taking a generic version of Paxil has renewed her fight to hold GlaxoSmithKline liable for allegedly inadequate warning labels on the antidepressant.